IL6 and COVID-19: COVID-19 is currently treated using antiviral drugs such as molnupiravir [22], nirmatrelvir [23], ritonavir [24], and remdesivir [25], anti-inflammatory drugs (dexamethasone [26]), immunomodulatory agents such as baricitinib and tocilizumab, an anti-IL-6 antibody [27], and monoclonal antibodies against the receptor binding domain such as sotrovimab [28].